1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional) is sponsored by National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH). MIRA provides support for the program of research in an investigator's laboratory that falls within the mission of NIGMS.
The goal is to increase funding efficiency by providing investigators with greater stability and flexibility over five-year grant periods, enhancing scientific productivity and the potential for important breakthroughs. This program also aims to distribute funding more widely among talented researchers. Early Stage Investigators should apply through PAR-27-032.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Public and private institutions of higher education including universities. Open to both established investigators/new investigators and early stage investigators. Early stage investigators should apply through PAR-27-032. Confirm the full requirements in the official notice before applying.
Applications for Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional) are due May 26, 2028. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional) is funded by National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PAR-27-056 replaces the long-running IDeA-CTR U54 cooperative agreement with a P30 center core grant and splits the program into Development and Network tracks. Posted August 19, 2026, with a first estimated due date of October 9. Here is what the mechanism swap actually changes for the 23 IDeA states and Puerto Rico.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read articlePAR-27-003 opens the NIGMS-style RM1 to 13 NIH institutes through September 2029: 3 to 6 PIs, up to $1.5M in direct costs a year but most awards $500K to $900K, at least 2.4 months of effort per PI, and a 20-page strategy with a mandatory Team Integration Plan. The NIGMS predecessor made 4 new awards in three years.
Read article